1.00 / AMA PRA Category 1 Credit(s)TM 1.00 / CE for Nurses 1.00 / CE for Psychologists
Jointly provided by Postgraduate Institute for Medicine (PIM) and Global Medical Education
Supported by an educational grant by Allergan
This activity highlights the role of atypical antipsychotics in the treatment of mood and psychotic disorders. This will include pharmacology, efficacy, and side effects. The latest advances in treating all phases of these illnesses, including treatment resistant patients, side effects of psychotropics and strategies to make patients active collaborators in their care will be discussed.
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, registered nurses, psychologists, social workers, and other healthcare professionals who treat patients with psychiatric illnesses.
Upon completion of the activity, participants should be better able to:
Discuss the evidence base for the efficacy and tolerability of atypical antipsychotics
Individualize treatment choices, giving consideration to long-term data and unique patient characteristics
Formulate appropriate treatment regimens considering the emergence of new investigative agents
Conflict Of Interest Disclosure Policy
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Prakash Masand, MD Chairman and CEO, Global Medical Education Adjunct Professor Duke-National University of Singapore Medical School
Dr. Masand discloses the following: Consultant: Allergan, Lundbeck, Merck, Otsuka, Pfizer, Sunovion, Takeda Research Support: Allergan, Merck Speakers Bureau: Allergan, GlaxoSmithKline, Lundbeck, Merck, Otsuka, Pfizer, Sunovion, Takeda.
Accredited Provider Disclosure
The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN, and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Publishing Staff Disclosures
Prakash Masand, MD, of Global Medical Education, has the following disclosures: Consultant: Allergan, Lundbeck, Merck, Otsuka, Pfizer, Sunovion, Takeda Research Support: Allergan, Merck Speaker’s Bureau: Allergan, Glaxo Smith Kline, Lundbeck, Merck, Otsuka, Pfizer, Sunovion, Takeda
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Global Medical Education. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.00 contact hour is provided by Postgraduate Institute for Medicine.
CE for Psychologists
Postgraduate Institute for Medicine (PIM) is approved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibility for this program and its content.
This program offers 1.00 continuing education credit for psychologists.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.